Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...

The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space ...

Cystic fibrosis is a genetic disorder that changes a vital protein in the body, causing a buildup of thick and sticky mucus, ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...

Perinatal dysfunction of innate immunity in cystic fibrosis.Sci. Transl. Med.17,eadk9145 (2025).DOI:10.1126/scitranslmed.adk9145 ...

The Bridgewater, N.J., biopharmaceutical company said brensocatib has the potential to become the first and only approved treatment for non-cystic fibrosis bronchiectasis, which causes the lungs' ...

Insmed (INSM) announced that the U.S. FDA has accepted the company’s New Drug Application for brensocatib for patients with non-cystic fibrosis ...

Some you might hold only temporarily, while others you own for decades. David Jagielski (Eli Lilly): A forever stock you can ...

When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

Some people with cystic fibrosis still do not have access to the life-changing modulator therapy drugs, despite wider EMA ...

By the time Enid Katz was two years old, she had already suffered through several bouts of bronchitis and was always hungry, ...